Cargando…
P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429401/ http://dx.doi.org/10.1097/01.HS9.0000969000.00342.16 |
| _version_ | 1785090703745875968 |
|---|---|
| author | Piciocchi, Alfonso Marconi, Giovanni Cipriani, Marta Messina, Monica Guolo, Fabio Minetto, Paola Paoloni, Francesca Cotugno, Francesca DI Donato, Laura Simonetti, Giorgia Palmieri, Raffaele Buccisano, Francesco Fazi, Paola Vignetti, Marco M. Lemoni, Roberto Venditti, Adriano Martinelli, Giovanni |
| author_facet | Piciocchi, Alfonso Marconi, Giovanni Cipriani, Marta Messina, Monica Guolo, Fabio Minetto, Paola Paoloni, Francesca Cotugno, Francesca DI Donato, Laura Simonetti, Giorgia Palmieri, Raffaele Buccisano, Francesco Fazi, Paola Vignetti, Marco M. Lemoni, Roberto Venditti, Adriano Martinelli, Giovanni |
| author_sort | Piciocchi, Alfonso |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429401 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104294012023-08-17 P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD Piciocchi, Alfonso Marconi, Giovanni Cipriani, Marta Messina, Monica Guolo, Fabio Minetto, Paola Paoloni, Francesca Cotugno, Francesca DI Donato, Laura Simonetti, Giorgia Palmieri, Raffaele Buccisano, Francesco Fazi, Paola Vignetti, Marco M. Lemoni, Roberto Venditti, Adriano Martinelli, Giovanni Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429401/ http://dx.doi.org/10.1097/01.HS9.0000969000.00342.16 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Piciocchi, Alfonso Marconi, Giovanni Cipriani, Marta Messina, Monica Guolo, Fabio Minetto, Paola Paoloni, Francesca Cotugno, Francesca DI Donato, Laura Simonetti, Giorgia Palmieri, Raffaele Buccisano, Francesco Fazi, Paola Vignetti, Marco M. Lemoni, Roberto Venditti, Adriano Martinelli, Giovanni P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD |
| title | P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD |
| title_full | P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD |
| title_fullStr | P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD |
| title_full_unstemmed | P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD |
| title_short | P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD |
| title_sort | p523: the comparison of vflai, flai and 3 + 7 regimens by multilevel propensity score weighting highlights the benefit of the addition of venetoclax in no low-risk aml treated in gimema trials and real world |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429401/ http://dx.doi.org/10.1097/01.HS9.0000969000.00342.16 |
| work_keys_str_mv | AT piciocchialfonso p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT marconigiovanni p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT ciprianimarta p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT messinamonica p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT guolofabio p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT minettopaola p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT paolonifrancesca p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT cotugnofrancesca p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT didonatolaura p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT simonettigiorgia p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT palmieriraffaele p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT buccisanofrancesco p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT fazipaola p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT vignettimarco p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT mlemoniroberto p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT vendittiadriano p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld AT martinelligiovanni p523thecomparisonofvflaiflaiand37regimensbymultilevelpropensityscoreweightinghighlightsthebenefitoftheadditionofvenetoclaxinnolowriskamltreatedingimematrialsandrealworld |